These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

88 related items for PubMed ID: 415919

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Effects and mode of action of Corynebacterium parvum on murine tumour metastases.
    Castro JE, Sadler TE, Jones PD.
    Dev Biol Stand; ; 38():277-81. PubMed ID: 608510
    [Abstract] [Full Text] [Related]

  • 25. Effects of Corynebacterium parvum treatment and Toxoplasma gondii infection on macrophage-mediated cytostasis of tumour target cells.
    Krahenbuhl JL, Lambert LH, Remington JS.
    Immunology; 1976 Dec; 31(6):837-46. PubMed ID: 992714
    [Abstract] [Full Text] [Related]

  • 26. Distribution of 3H-thymidine-labelled C. parvum in mice.
    Sadler TE, Cramp WA, Castro JE.
    Dev Biol Stand; 1976 Dec; 38():137-43. PubMed ID: 608501
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Alterations of host resistance to Listeria monocytogenes in tumour-bearing mice and the effect of Corynebacterium parvum.
    Miyata H, Himeno K, Miake S, Nomoto K.
    Immunology; 1981 Oct; 44(2):305-10. PubMed ID: 7298070
    [Abstract] [Full Text] [Related]

  • 29. Immunological enhancement of leukemia L1210 by Corynebacterium parvum in allogeneic mice.
    Berd DA, Mitchell MS.
    Cancer Res; 1976 Nov; 36(11 Pt 1):4119-24. PubMed ID: 975053
    [Abstract] [Full Text] [Related]

  • 30. Enhancement of thermal response of normal and malignant tissues by Corynebacterium parvum.
    Urano M, Yamashita T, Suit HD, Gerweck LE.
    Cancer Res; 1984 Jun; 44(6):2341-7. PubMed ID: 6722772
    [Abstract] [Full Text] [Related]

  • 31. The effect of Corynebacterium parvum on the humoral and cellular immune systems in patients with breast cancer.
    Minton JP, Rossio JL, Dixon B, Dodd MC.
    Clin Exp Immunol; 1976 Jun; 24(3):441-7. PubMed ID: 1084821
    [Abstract] [Full Text] [Related]

  • 32. Simple estimation of macrophage activity in tumour-bearing animals treated with Corynebacterium parvum.
    Wilson RG.
    Br J Exp Pathol; 1981 Aug; 62(4):347-9. PubMed ID: 7295527
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Studies using labelled C. parvum preparations in mice.
    Scott MT.
    Dev Biol Stand; 1981 Aug; 38():123-7. PubMed ID: 608498
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. [Antitumor effect of Corynebacterium parvum on C3H mouse bearing MH-134 tumor].
    Nakamura K, Miwa H, Hashimoto O, Inoue T, Orita K.
    Gan To Kagaku Ryoho; 1982 Jul; 9(6):1046-51. PubMed ID: 7184438
    [Abstract] [Full Text] [Related]

  • 38. Characteristics of resistance to Listeria monocytogenes enhanced by Corynebacterium parvum in mice.
    Miyata H, Nomoto K, Takeya K.
    Immunology; 1980 May; 40(1):33-9. PubMed ID: 6968291
    [Abstract] [Full Text] [Related]

  • 39. Mechanisms of the potentiation of specific antitumor immunity by intratumor injection of Corynebacterium parvum.
    Miyata H, Himeno K, Nomoto K.
    Cancer Res; 1983 Oct; 43(10):4670-5. PubMed ID: 6883325
    [Abstract] [Full Text] [Related]

  • 40. Mechanism of action of C. parvum on a solid, subcutaneous mouse tumour.
    Jones PD, Sadler TE, Castro JE.
    Dev Biol Stand; 1983 Oct; 38():259-64. PubMed ID: 204533
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.